CEO Margo Georgiadis said that the company has "seen a slowdown in consumer demand across the entire DNA category."
The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.
The fledgling company, started as a promise to the founder's dying sister, is trying to succeed in a consumer niche where so many others have failed.
Despite the availability of more precision therapies and complex biomarker tests, systemic gaps and lack of physician education continued to hinder access.
The company will use the funding to market its GoodCell Diagnostics service, which combines genetic testing and personally controlled biobanking.
The clinical decision support content developer is integrating genetic testing information into its knowledgebase to assist physicians at the point of care.
Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.
The acquisition, slated to close in the coming days, will give Invitae access to Clear Genetics' chatbot Gia, or Genetic Information Assistant.
The decade-long project will no longer enroll participants, but research using the collected data will continue.
The company launched a "core" service using Illumina microarray genotyping, and has plans for an expanded NGS offering with Quest Diagnostics.
The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.
Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.
Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.
In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.